Editor's note: This article originally appeared in our sister publication, Pharmacy Practice News.
On Aug. 30, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend the Pfizer-BioNTech messenger RNA (mRNA) COVID-19 vaccine (Comirnaty) for people 16 years of age and older under the FDA’s Biologics License Application approval.
The 14-member panel agreed that the benefits of vaccination against COVID-19 far outweighed the risks. The vote follows